.jpg?width=800&height=600&name=REPROCELL-04.06.18_0460%20(1).jpg)
Our human tissue platform technologies
At REPROCELL, we offer a unique range of experimental techniques for translating data from preclinical species to humans. Explore our platform technologies.
For Preclinical Drug Developers
Preclinical and Drug Discovery CRO
REPROCELL Biopta’s human tissue technology predicts clinical success by using the closest possible model of drug behavior in humans.
Human tissue testing is a translational approach to drug discovery that bridges the gap between animal studies and clinical trials — increasing clinical success rates and adding commercial value to preclinical drug assets through proof of concept in patient-derived living tissues.
Which drug discovery challenges do you face?
-jpg.jpeg?width=500&height=333&name=REPROCELL-04-06-18_0019%20(1)-jpg.jpeg)
Are you seeking proof of concept for your novel drug therapy?
Demonstrate human efficacy and safety in human living tissues, capturing real-world patient data.
Explore our range of human fresh tissue assays.
Are you managing a discovery pipeline in biotech or pharma?
Generate commercial value and de-risk your preclinical assets through human data.
View our case studies on human fresh tissue assays.
Troubleshooting clinical safety
REPROCELL has expertise in human fresh tissue safety pharmacology and cross-species comparative studies – to GLP if required.
We can help by generating data in human functional tissues.
From Target to Treatment Accelerating Drug Discovery with Human-Relevant Insights
By combining advanced in vitro systems, patient-derived tissues, and data-rich analysis at every stage, we help bridge the gap between discovery and the clinic, enabling more confident decision-making and increasing the likelihood of clinical success.
.jpg?width=1280&height=720&name=PDD%20flow%20(1).jpg)
Alvetex® bioengineered 3D tissue services
Complementing our fresh tissue assays by accurately recreating human biology in bioengineered tissues.
Examples of our work
Our expertise in all areas of human tissue testing — including ethics, sourcing, handling, and fee-for-service experiments in human fresh tissue — allows us to act as your human tissue research department. See all our case studies.
Managing risks and saving money
Human fresh tissue can be used to manage risk and save money across the entire drug discovery pipeline.
Demonstrating efficacy and safety
Human fresh tissue can be used in all phases of drug discovery programs, from target validation to clinical trouble shooting.
Join our human tissue supplier network
We are investing in our tissue network to meet the growing safety and efficacy requirements of drug development programs and medicine regulators around the globe.
Clinical Laboratory Services
We coordinate, process, test, and analyze a range of fresh human biospecimens to meet the demands of your clinical research.
Pharmacology-AI
Machine learning platform for rapid identification of the features driving variation in patient outcomes — streamlining the development of effective patient stratification strategies.
On the REPROCELL blog
Latest in Drug Discovery
.jpg?width=756&height=425&name=New%20Approach%20Methodologies%20(NAMs).jpg)
The Resurgence of New Approach Methodologies (NAMs) in Drug Discovery and Safety Assessment
Explore how New Approach Methodologies are revolutionizing drug discovery and safety assessment by enhancing human-relevant research and reducing reliance on animal testing.
30 April 2026
Mapping the Competitive Landscape of Human Tissue-Based Drug Discovery
Explore how REPROCELL leads in human tissue-based drug discovery, addressing market gaps and offering innovative, disease-relevant solutions for better therapeutic outcomes.
02 April 2026
Donor Variability in Ex Vivo Human Tissue Studies: Challenge, Feature, or Translational Advantage
Explore how donor variability in ex vivo human tissue studies enhances translational research by providing insights into patient heterogeneity and improving drug discovery.
12 March 2026